Delivery Order SPE2DB25D3017-SPE2DB25FVKTE
- Not listed
- The Defense Logistics Agency awarded a $6,048.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on October 31, 2025, with completion scheduled for November 3, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $20,163.79 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injections on September 24, 2025, with completion scheduled for September 25, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $2,176.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injections on October 31, 2025, with completion scheduled for November 3, 2025. This contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency awarded a $35,203.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and running through December 2026. The medication will be delivered to...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,431.03 delivery order on July 25, 2025, for Mounjaro 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,246.48 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 ml pen injections on June 18, 2025. This is a firm fixed price, non-set-aside contract with a completion date of June 20, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $2,225.01 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen injections on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December...
- The Defense Logistics Agency awarded a $26,926.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors. The contract, which is not set-aside, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. Performance will be completed by October 28, 2025, with fulfillment occurring at...
- The Defense Logistics Agency awarded a $5,441.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injections (0.5 ml). This is a non-set-aside competitive award with an ultimate completion date of September 29, 2025. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,030.74 delivery order to AmerisourceBergen Drug Corp for Mounjaro 2.5 mg/0.5 mL pen injections on November 4, 2025, with completion scheduled for November 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVKTEDelivery Order
The Defense Logistics Agency awarded a $54,938.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Mounjaro 2.5 mg/0.5 ml pen injections. This non-set-aside contract is categorized as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with final completion scheduled for September 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive DLA contract vehicle that supports military healthcare programs globally. The company's IDC encompasses a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications across multiple therapeutic domains. This delivery order for Mounjaro—a diabetes medication—exemplifies the type of brand-name pharmaceutical products routinely procured through AmerisourceBergen's federal contracts to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $54.9k | 9/22/25 |